FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2007885181> ?p ?o ?g. }

• W2007885181 endingPage "278" @default.
• W2007885181 startingPage "272" @default.
• W2007885181 abstract "One developing strategy for obesity treatment has been to use combinations of differently acting pharmacotherapies to improve weight loss with fewer adverse effects. The purpose of this study was to determine whether the combination of naltrexone (Nal), an opioid antagonist acting on the reward system, and exendin-4 (Ex-4), a glucagon-like peptide 1 agonist acting on satiety signaling, would produce larger reductions in food intake than either alone in rats. Because the anorectic potencies of both compounds have been associated with nausea and malaise, the influence of these drug combinations on the acquisition of a conditioned taste aversion (CTA) was also determined.In Experiment 1, the acute anorectic effects of Nal (0.32-3.2 mg kg(-1); intraperitoneally (i.p.)) and Ex-4 (1-10 μg kg(-1); i.p.) were assessed alone or in combination. Combinational doses were further investigated by the repeated daily administration of 1 mg kg(-1) Nal+3.2 μg kg(-1) Ex-4 for 4 days. In Experiment 2, both compounds alone or in combination were used as unconditioned stimuli in a series of CTA tests.Nal and Ex-4, alone or in combination, suppressed food intake in a dose-dependent manner, and the interaction on food intake between Nal and Ex-4 was additive. In the CTA paradigm, Nal (1 mg kg(-1)) alone did not support acquisition, whereas a CTA was evident with doses of Ex-4 (1 or 3.2 μg kg(-1)). Combinations of Nal and Ex-4 also resulted in a more rapid and robust acquisition of a CTA.Given that the Nal and Ex-4 combination produces additive effects on not only food intake reduction but also food aversion learning, this specific drug combination does not have the benefit of minimizing the adverse effects associated with each individual drug. These data suggest that it is necessary to evaluate both the positive and adverse effects at early stages of combinational drug development." @default.
• W2007885181 created "2016-06-24" @default.
• W2007885181 creator A5009982619 @default.
• W2007885181 creator A5025175833 @default.
• W2007885181 creator A5058772320 @default.
• W2007885181 date "2012-02-07" @default.
• W2007885181 modified "2023-10-16" @default.
• W2007885181 title "Additive feeding inhibitory and aversive effects of naltrexone and exendin-4 combinations" @default.
• W2007885181 cites W1528744700 @default.
• W2007885181 cites W1936375955 @default.
• W2007885181 cites W1963621734 @default.
• W2007885181 cites W1965072462 @default.
• W2007885181 cites W1965321234 @default.
• W2007885181 cites W1966059930 @default.
• W2007885181 cites W1970250630 @default.
• W2007885181 cites W1975566161 @default.
• W2007885181 cites W1975854820 @default.
• W2007885181 cites W1978612567 @default.
• W2007885181 cites W1983054659 @default.
• W2007885181 cites W1983901940 @default.
• W2007885181 cites W1986085856 @default.
• W2007885181 cites W1986967808 @default.
• W2007885181 cites W1997801326 @default.
• W2007885181 cites W1998882505 @default.
• W2007885181 cites W2008480577 @default.
• W2007885181 cites W2013665956 @default.
• W2007885181 cites W2019131037 @default.
• W2007885181 cites W2026212466 @default.
• W2007885181 cites W2031980398 @default.
• W2007885181 cites W2037794724 @default.
• W2007885181 cites W2046670077 @default.
• W2007885181 cites W2047669043 @default.
• W2007885181 cites W2055631198 @default.
• W2007885181 cites W2057410639 @default.
• W2007885181 cites W2062285900 @default.
• W2007885181 cites W2070710390 @default.
• W2007885181 cites W2082052031 @default.
• W2007885181 cites W2083515545 @default.
• W2007885181 cites W2086623735 @default.
• W2007885181 cites W2090615791 @default.
• W2007885181 cites W2093738306 @default.
• W2007885181 cites W2097590641 @default.
• W2007885181 cites W2102171567 @default.
• W2007885181 cites W2117638217 @default.
• W2007885181 cites W2124762650 @default.
• W2007885181 cites W2128660756 @default.
• W2007885181 cites W2140625608 @default.
• W2007885181 cites W2144343807 @default.
• W2007885181 cites W2144589456 @default.
• W2007885181 cites W2153367452 @default.
• W2007885181 cites W2162941228 @default.
• W2007885181 cites W2169611151 @default.
• W2007885181 cites W2274589954 @default.
• W2007885181 doi "https://doi.org/10.1038/ijo.2012.16" @default.
• W2007885181 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3383881" @default.
• W2007885181 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22310470" @default.
• W2007885181 hasPublicationYear "2012" @default.
• W2007885181 type Work @default.
• W2007885181 sameAs 2007885181 @default.
• W2007885181 citedByCount "25" @default.
• W2007885181 countsByYear W20078851812012 @default.
• W2007885181 countsByYear W20078851812013 @default.
• W2007885181 countsByYear W20078851812014 @default.
• W2007885181 countsByYear W20078851812015 @default.
• W2007885181 countsByYear W20078851812016 @default.
• W2007885181 countsByYear W20078851812017 @default.
• W2007885181 countsByYear W20078851812019 @default.
• W2007885181 countsByYear W20078851812020 @default.
• W2007885181 countsByYear W20078851812021 @default.
• W2007885181 countsByYear W20078851812022 @default.
• W2007885181 countsByYear W20078851812023 @default.
• W2007885181 crossrefType "journal-article" @default.
• W2007885181 hasAuthorship W2007885181A5009982619 @default.
• W2007885181 hasAuthorship W2007885181A5025175833 @default.
• W2007885181 hasAuthorship W2007885181A5058772320 @default.
• W2007885181 hasBestOaLocation W20078851811 @default.
• W2007885181 hasConcept C126322002 @default.
• W2007885181 hasConcept C134018914 @default.
• W2007885181 hasConcept C164742699 @default.
• W2007885181 hasConcept C170493617 @default.
• W2007885181 hasConcept C185592680 @default.
• W2007885181 hasConcept C2775962371 @default.
• W2007885181 hasConcept C2776398474 @default.
• W2007885181 hasConcept C2776885963 @default.
• W2007885181 hasConcept C2777180221 @default.
• W2007885181 hasConcept C2777369949 @default.
• W2007885181 hasConcept C2777972943 @default.
• W2007885181 hasConcept C2778750930 @default.
• W2007885181 hasConcept C2778938600 @default.
• W2007885181 hasConcept C3018685816 @default.
• W2007885181 hasConcept C31903555 @default.
• W2007885181 hasConcept C555293320 @default.
• W2007885181 hasConcept C71924100 @default.
• W2007885181 hasConcept C8868529 @default.
• W2007885181 hasConcept C98274493 @default.
• W2007885181 hasConceptScore W2007885181C126322002 @default.
• W2007885181 hasConceptScore W2007885181C134018914 @default.
• W2007885181 hasConceptScore W2007885181C164742699 @default.

• next